Filing Flows › Health Care › Teladoc Health (TDOC)
Teladoc Health (TDOC) earnings and revenue breakdown
Latest: Q3 2026 · 10-Q filed Oct 29, 2026 · Teladoc Health (TDOC) Q3 2026 earnings results →
Q3 2026 Revenue down 3% year over year to $605M · 4¢ of every $1 of revenue lost · operating margin -4.6%
Teladoc Health made $605M in Q3 2026 (-3% Y/Y): Access Fees $467M, Other $138M. Operating margin -4.6%, net loss $26.9M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Oct 29, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $605.1M in Q3 2026, down 3% year over year and roughly flat from the previous quarter. Access Fees was the largest line at 77% of revenue. Access Fees lost $54.2M year over year (down 10%), 254% of the total change.
Operating costs exceeded revenue by $28.1M, an operating margin of -4.6%. Total costs fell 7% while revenue fell 3%. The quarter ended with a net loss of $26.9M, narrower than the previous quarter's $38.9M loss.
Operating cash flow was $106.5M (up 7% year over year). Non-cash charges added back $11.6M of share-based compensation. Working capital and other items added $121.8M. Capital expenditures of $1.2M left free cash flow of $105.2M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 10-Q | Oct 29, 2026 | $605M | -3% | -4.6% | −$26.9M | $106M |
| Q2 2026 | 10-Q | Jul 30, 2026 | $607M | -4% | -6.1% | −$38.9M | $64.7M |
| Q1 2026 | 10-Q | Apr 30, 2026 | $614M | -2% | -10.1% | −$63.8M | $9.5M |
| Q4 2025 | 10-K | Feb 26, 2026 | $642M | +0.3% | -5.6% | −$25.1M | $87.7M |
| Q3 2025 | 10-Q | Oct 30, 2025 | $626M | -2% | -8.3% | −$49.5M | $99.3M |
| Q2 2025 | 10-Q | Jul 30, 2025 | $632M | -2% | -8.6% | −$32.7M | $91.4M |
| Q1 2025 | 10-Q | May 1, 2025 | $629M | -3% | -19.2% | −$93.0M | $15.9M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Teladoc Health
Teladoc Health is the global leader in virtual care. More than 20 years ago, we were founded on a simple, yet revolutionary idea: that everyone should have access to the best healthcare, anywhere in the world on their terms. Our mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. Today, we are transforming virtual care into a catalyst for how better health happens around the world. We connect patients, care providers, healthcare platforms and partners to provide more complete and personalized care. Through our unique technology, breadth of services and depth of clinical expertise, we are delivering and orchestrating care in order to improve health outcomes and reduce healthcare costs around the world.
In its own words, from its 10-K, filed Feb 26, 2026.
Teladoc Health against its Services-Offices & Clinics of Doctors of Medicine peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -3% against the peers' median -3%. Operating margin: -4.6% against the peers' median -12.9%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| TDOC Teladoc Health | Q3 2026 | $605M | -3% | -4.6% |
| HIMS Hims & Hers Health | Q2 2026 | $753M | +38% | -12.9% |
| STLN Starling Oncology | Q3 2026 | $170M | +24% | -1.8% |
| SBC SBC Medical Group Holdings | Q2 2026 | $49.2M | +13% | 38.5% |
| LFMD LifeMD | Q2 2026 | $47.3M | -4% | -15.1% |
| AIRS Airsculpt Technologies | Q3 2026 | $31.9M | -9% | -13.0% |
| CDIX Cardiff Lexington | Q2 2026 | $2.2M | -23% | -25.2% |
| HLYK HealthLynked | Q2 2026 | $250K | -58% | -215.7% |
Source: Teladoc Health 10-Q on SEC EDGAR · CIK 1477449 · Services-Offices & Clinics of Doctors of Medicine
Guidance and outlook
13F: who owns TDOC and who is buying
More on TDOC
History
Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results